Better NPL Outlook, But Upside to Yields Uncertain
UOB (SGX:U11)’s 3Q20 PAT was behind MKE & in-line with Street. Lowered credit charge guidance and limited NPL formation despite moratoriums unwinding are positive developments. Nevertheless, the operating environment remains uncertain and low NIMs are likely to continue.
We believe improved PAT from lower provisions may not flow through to higher dividends in 2021E given regulatory moratoriums. This may cap yields in the near term.
We have raised Target Price to SGD21.24, but maintain HOLD.
Better Outlook for Asset Quality
At 68bps, 3Q20 credit charges were similar to 2Q20 – but 72% was cautionary GP. Management claims the GP build up is to cover potential risks in 2021E as well. That said, 2020-2021E credit charge guidance has been lowered to 100bps (from a high of 130bps earlier).
New NPL creation fell 43% q-o-q and upgrades/recoveries increased 71%. Management claims the expiry of Malaysian moratoriums have not exposed much weakness.
UOB has been doing bottom up analysis of its portfolios under relief and expects NPL formation to be slower than initially expected. As a result, we have lowered UOB's 2020E-2022E credit charges by 12-35% and NPA balances by 15-29%.
But, given uneven economic recovery, downside risks remain.
Operational Uncertainty Remains
UOB's NIMs continue to be pressured in 3Q (-24bps y-o-y). Management claims it may have bottomed, but we believe recovery may be some way off given expectations of lower policy rates regionally.
We expect loans to see some improvement in 2021E (+7% y-o-y) led by SE Asian markets.
Overall, regional recovery in 3Q20 has been lacklustre with PPOP rising 4% q-o-q in Singapore & ASEAN, while North Asia saw a 14% q-o-q decline. Continued risks of regional COVID-19 lockdowns and travel bans may prolong recovery visibility.
We have lowered UOB's 2020E PAT by 4% but raise 2021-22E by 2-8%.
Dividend Caps in 2021E? Maintain HOLD
The elephant in the room is whether regulatory dividend caps (60% of 2019 DPS) will be extended into 2021E. We believe given the infancy of macro recovery and the need to preserve confidence in systemic capital and liquidity, there is a high probability it is extended. As a result, UOB's 2021E operational improvements may not necessarily translate to dividend yield.
We have rolled forward our multi-stage DDM (COE 9.7%, 3% terminal) to 2021E and raised UOB's target price to S$21.24. With 9% upside, maintain HOLD.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....